MAUNA KEA TECHNOLOGIES (MKEA.PA) Fundamental Analysis & Valuation

EPA:MKEAFR0010609263

Current stock price

0.62 EUR
0 (0%)
Last:

This MKEA.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MKEA.PA Profitability Analysis

1.1 Basic Checks

  • In the past year MKEA has reported negative net income.
  • In the past year MKEA has reported a negative cash flow from operations.
MKEA.PA Yearly Net Income VS EBIT VS OCF VS FCFMKEA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

  • MKEA has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MKEA.PA Yearly ROA, ROE, ROICMKEA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 -2K -4K -6K

1.3 Margins

  • With a Gross Margin value of 9.79%, MKEA is not doing good in the industry: 86.21% of the companies in the same industry are doing better.
  • The Profit Margin and Operating Margin are not available for MKEA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MKEA.PA Yearly Profit, Operating, Gross MarginsMKEA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -50 -100 -150 -200

1

2. MKEA.PA Health Analysis

2.1 Basic Checks

  • MKEA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for MKEA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MKEA.PA Yearly Shares OutstandingMKEA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M
MKEA.PA Yearly Total Debt VS Total AssetsMKEA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M

2.2 Solvency

  • MKEA has an Altman-Z score of -2.19. This is a bad value and indicates that MKEA is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -2.19, MKEA is doing worse than 87.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.19
ROIC/WACCN/A
WACC6.43%
MKEA.PA Yearly LT Debt VS Equity VS FCFMKEA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 1.19 indicates that MKEA should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.19, MKEA is not doing good in the industry: 75.86% of the companies in the same industry are doing better.
  • MKEA has a Quick Ratio of 1.19. This is a bad value and indicates that MKEA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of MKEA (0.94) is worse than 63.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.94
MKEA.PA Yearly Current Assets VS Current LiabilitesMKEA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M

2

3. MKEA.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.86% over the past year.
  • The Revenue has decreased by -2.87% in the past year.
  • Measured over the past years, MKEA shows a small growth in Revenue. The Revenue has been growing by 2.26% on average per year.
EPS 1Y (TTM)28.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.82%
Revenue 1Y (TTM)-2.87%
Revenue growth 3Y0.21%
Revenue growth 5Y2.26%
Sales Q2Q%-6.79%

3.2 Future

  • MKEA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.59% yearly.
  • The Revenue is expected to decrease by -2.76% on average over the next years.
EPS Next Y-62.13%
EPS Next 2Y72.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-18.48%
Revenue Next 2Y-2.76%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MKEA.PA Yearly Revenue VS EstimatesMKEA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MKEA.PA Yearly EPS VS EstimatesMKEA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -0.2 -0.4 -0.6 -0.8

1

4. MKEA.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • MKEA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year MKEA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MKEA.PA Price Earnings VS Forward Price EarningsMKEA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MKEA.PA Per share dataMKEA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

  • MKEA's earnings are expected to grow with 72.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.59%
EPS Next 3YN/A

0

5. MKEA.PA Dividend Analysis

5.1 Amount

  • MKEA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MKEA.PA Fundamentals: All Metrics, Ratios and Statistics

MAUNA KEA TECHNOLOGIES

EPA:MKEA (8/7/2023, 7:00:00 PM)

0.62

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.74M
Revenue(TTM)7.48M
Net Income(TTM)-11.18M
Analysts87.5
Price Target1.99 (220.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-338.12%
EPS NY rev (3m)-338.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-32.43%
Revenue NY rev (3m)-32.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.84
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0.16
BVpS-0.43
TBVpS-0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.79%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.47%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.94
Altman-Z -2.19
F-Score2
WACC6.43%
ROIC/WACCN/A
Cap/Depr(3y)48.95%
Cap/Depr(5y)75.01%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.82%
EPS Next Y-62.13%
EPS Next 2Y72.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.87%
Revenue growth 3Y0.21%
Revenue growth 5Y2.26%
Sales Q2Q%-6.79%
Revenue Next Year-18.48%
Revenue Next 2Y-2.76%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-833.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.06%
OCF growth 3YN/A
OCF growth 5YN/A

MAUNA KEA TECHNOLOGIES / MKEA.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MAUNA KEA TECHNOLOGIES?

ChartMill assigns a fundamental rating of 1 / 10 to MKEA.PA.


What is the valuation status for MKEA stock?

ChartMill assigns a valuation rating of 1 / 10 to MAUNA KEA TECHNOLOGIES (MKEA.PA). This can be considered as Overvalued.


What is the profitability of MKEA stock?

MAUNA KEA TECHNOLOGIES (MKEA.PA) has a profitability rating of 0 / 10.


Can you provide the financial health for MKEA stock?

The financial health rating of MAUNA KEA TECHNOLOGIES (MKEA.PA) is 1 / 10.